Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Prism 302-A Three-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self Administered by Adults with Phenylketonuria
Fuchs, George
(PI)
Briggs, Alissa
(CoI)
Crutcher, Angela
(CoI)
Yozwiak, John
(CoI)
Amato, Ralph
(Former PI)
Pediatrics
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
6/19/14
→
2/12/20
Funding
BioMarin Pharma Inc:
$914,348.00
View all
View less